← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 21, 2020Last known activity
Oct 6, 2025
Timeline
2010s
- Jun 1, 2018
Imbria Pharmaceuticals— Founded
Drugs by trial phase (1 distinct, 5 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT07023614Lead sponsorPhase 2Oct 6, 2025
- NCT04826185Study directorPhase 2Jun 14, 2021
- NCT04826185Lead sponsorPhase 2Jun 14, 2021
- NCT04826172Study directorPhase 2Apr 23, 2021
- NCT04826172Lead sponsorPhase 2Apr 23, 2021
- NCT04826159Lead sponsorPhase 2Apr 21, 2021
- NCT04826159Study directorPhase 2Apr 21, 2021
- NCT04306237Study directorPhase 2Mar 21, 2020
- NCT04306237Lead sponsorPhase 2Mar 21, 2020
Details
- Founded
- Boston, MA, US Jun 1, 2018
- Last known activity
- Oct 6, 2025